A crucial type of defensive blood cell persists for at least six months in people after Covid-19, even in those who had no symptoms, in a new study that may ease concern about waning immunity and its implications for a vaccine.
The research on 100 people shows that all had T-cell responses against a range of the coronavirus’s proteins, including the spike protein used as a marker in many vaccine studies, after half a year. Those who experienced symptoms had levels that were at least 50% higher than those who didn’t. As a handful of vaccines nears the finish line, it’s still unclear how long any protection they afford would last. A small number of patients have fallen ill with Covid-19 twice.
“This is promising news,” said Fiona Watt, executive chair of the UK’s Medical Research Council. “If natural infection with the virus can elicit a robust T-cell response, then this may mean that a vaccine could do the same.”
Read More: Covid-19: From worst-hit US to South Africa, countries that have flattened the curve
A previous study, published last month by Imperial College London, raised concern that immune defenses may wane, as it showed that the percentage of Britons with antibodies declined over time. T cells aren’t antibodies. They are white blood cells that can remember past diseases, kill virus-infected cells and rouse antibodies to marshal defenses when they are needed. People infected with another coronavirus that was responsible for the SARS epidemic in 2003, for example, still have a T-cell response to the disease 17 years later.
{{/usCountry}}A previous study, published last month by Imperial College London, raised concern that immune defenses may wane, as it showed that the percentage of Britons with antibodies declined over time. T cells aren’t antibodies. They are white blood cells that can remember past diseases, kill virus-infected cells and rouse antibodies to marshal defenses when they are needed. People infected with another coronavirus that was responsible for the SARS epidemic in 2003, for example, still have a T-cell response to the disease 17 years later.
{{/usCountry}}Also, read: Immunity-boosting diet 101: What you need to eat each season to stay strong
The study, from the a group of immunologists from 17 universities called the UK Coronavirus Immunology Consortium, has not yet been peer reviewed. It may be the first to show that a robust cellular memory against the virus persists for this long, the authors said.
None of the patients whose blood and serum samples were studied had been hospitalized with Covid-19.
Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.